Ann: Change of Director's Interest Notice - J Moore, page-23

First 23 Last

Share
Profile

Follow
nelson_peltz

83 Posts.

13

02/12/20

16:19

Post #: 49301523
Share

Originally posted by Kalenn: ↑

IMO the only real risk here is the opportunity cost if it takes longer than expected. I do not imagine for one second that the Myanmar government would want to; a) sully their reputation in international investment markets, b) miss out on the cudos of the jobs generated in an high unemployment rural area or miss out for years to come on that important PSA agreement money. The spreadsheets I throw up are also an indication of the enormous sums that will flow to government within 2 to 3 years once MIC license granted.

Yes, technically, there is a risk that something could go seriously wrong but that risk is getting increasingly small and has been approaching zero for the past 3 years. The above are just a few of the risk mitigating factors.

Every event that takes us closer to finalisation of the MIC also takes the risk closer to zero and the reward closer to substantial!

You can remove all risk for yourself by selling, but of course that removes all chance of success as well.

In the meantime, the company states clearly that they expect the invitation to submit the MIC to arrive this month. If they thought differently I believe they would notify the market. I fully expect they will receive the invitation to submit MIC application within weeks. Most likely in December but if not then shortly after.

The company (and who is in a better position to judge this?) has suggested December submission and typically an 8 week process to get through to the awarding of the MIC licence.

Even though I too would like it yesterday, it seems a very modest time to wait.

Expand

There is very little risk remaining outside the submission process.
That process itself now, IMO, carries very little risk given managements recent comments.
This is why I remain confident that we will submit in December.

MYL Price at posting: 7.6¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

There are more pages in this discussion • 161 more messages in this thread...

First 23 Last

Add MYL (ASX) to my watchlist

Ann: Change of Director's Interest Notice - J Moore, page-23

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Featured News